CSIG-03. PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1 (PELP1) PROMOTES GLIOBLASTOMA PROGRESSION VIA β-CATENIN PATHWAY

Glioblastomas (GBM) have dismal survival rates (1 year-34.6% and 5 year-4.75%) and affect 13,000 patients per year. Standard treatment consists of surgical resection, external beam radiation therapy, adjuvant chemotherapy with temozolomide and tumor treating fields. Nonetheless, despite a heavy inve...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Sareddy, Gangadhara Reddy, Zhou, Mei, Liu, Jinyou, Viswanadhapalli, Suryavathi, Gruslova, Aleksandra, Brann, Darrell, Brenner, Andrew, Vadlamudi, Ratna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692510/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.198
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia